Neuroone Medical Technologies (NMTC) Net Income Growth (1y) (2011 - 2026)
Neuroone Medical Technologies (NMTC) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.15 Bn | 176.85 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.85 Bn | 125.98 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 68.66 Bn | 67.21 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.24 Bn | 44.57 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 28.32 Bn | 26.03 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.18 Bn | 2.07 Bn | 125.69% |
| 10 | Neuroone Medical Technologies | 15.94 Mn | 13.14 Mn | 990,264.00 | -4.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.91% |
| Dec 31, 2025 | -180.54% |
| Sep 30, 2025 | 51.67% |
| Jun 30, 2025 | 45.77% |
| Mar 31, 2025 | 20.47% |
| Dec 31, 2024 | 153.37% |
| Sep 30, 2024 | -6.87% |
| Jun 30, 2024 | 20.22% |
| Mar 31, 2024 | 18.95% |
| Dec 31, 2023 | -93.04% |
| Sep 30, 2023 | -128.12% |
| Jun 30, 2023 | -25.69% |
| Mar 31, 2023 | -15.20% |
| Dec 31, 2022 | 38.28% |
| Sep 30, 2022 | 88.00% |
| Jun 30, 2022 | 6.50% |
| Mar 31, 2022 | -27.74% |
| Dec 31, 2021 | -43.28% |
| Sep 30, 2021 | -203.59% |
| Jun 30, 2021 | 58.38% |